Market Place
Sourcing Support
DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions
The first quarter (Q1) of 2025 witnessed an impressive surge in Drug Master File (DMF) submissions t
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
FDA reports 62.5% growth in new drug approvals in H1 2023; Health Canada sees drop
After a year when
drug approvals by the US Food and Drug Administration
(FDA) slipped to the lowes
